Literature DB >> 27546796

The two most popular malnutrition screening tools in the light of the new ESPEN consensus definition of the diagnostic criteria for malnutrition.

Kalliopi-Anna Poulia1, Stanislaw Klek2, Ioannis Doundoulakis3, Emmanouil Bouras3, Dimitrios Karayiannis4, Aristea Baschali4, Marili Passakiotou5, Michael Chourdakis6.   

Abstract

BACKGROUND: The new definition of malnutrition in adults proposed recently by The European Society for Clinical Nutrition and Metabolism (ESPEN) changed the view on the issue and raised the question of the reliability of available diagnostic tools. Therefore, the aim of this study was to verify the accuracy of the two most commonly used screening tools by comparing their findings with the new ESPEN criteria.
METHODS: Nutritional screening was performed in 1146 (median age 60 years, interquartile range: 44-73 years, 617 males, 529 females) patients on admission to hospitals with two nutritional screening tools: Nutritional Risk Screening 2002 (NRS2002) and Malnutrition Universal Screening Tool (MUST). The screening results were then compared to the ESPEN new diagnostic criteria for malnutrition.
RESULTS: According to the NRS2002 13.5% and 27.9% of the outpatients and hospitalized patients respectively were found to be at moderate/high risk of malnutrition. With the use of MUST 9.1% and 14.9% of the outpatients and hospitalized patients respectively were found to be at moderate/high risk of malnutrition. According to the ESPEN diagnostic criteria 6.4% and 11.3% of outpatients and hospitalized patients respectively were classified as malnourished. MUST was found to be better correlated to the latter for both outpatients (K = 0.777, p < 0.001) and hospitalized patients (K = 0.843, p < 0.001) as compared to NRS2002 (k = 0.256, p < 0.001 and k = 0.228, p < 0.001). ROC plots Area Under the Curve (AUC) was found to be higher for MUST compared to NRS2002 (0.964 vs. 0.695 for outpatients and 0.980 vs 0.686 for hospitalized patients respectively).
CONCLUSION: To our knowledge, this study is the first to analyze the clinical value of a malnutrition screening tool in the light of the new ESPEN definition for malnutrition. According to our results, MUST was better correlated with ESPEN criteria for the definition of malnutrition, leading us to the conclusion that it can more efficiently identify the malnourished patients, during the screening process.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Diagnostic criteria; Disease related malnutrition; ESPEN malnutrition definition; Nutritional screening; Screening tools

Mesh:

Year:  2016        PMID: 27546796     DOI: 10.1016/j.clnu.2016.07.014

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  28 in total

1.  Comparison of nutrition screening tools and calf circumference in estimating the preoperative prevalence of malnutrition among patients with aerodigestive tract cancers-a prospective observational cohort study.

Authors:  Nivedhyaa Srinivasaraghavan; Meenakshi V Venketeswaran; Kalpana Balakrishnan; Thendral Ramasamy; Aishwarya Ramakrishnan; Ajit Agarwal; Arvind Krishnamurthy
Journal:  Support Care Cancer       Date:  2022-04-29       Impact factor: 3.603

2.  Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown.

Authors:  Patricia Yárnoz-Esquíroz; Ana Chopitea; Laura Olazarán; Maite Aguas-Ayesa; Camilo Silva; Anna Vilalta-Lacarra; Javier Escalada; Ignacio Gil-Bazo; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Nutrients       Date:  2022-07-02       Impact factor: 6.706

3.  Nutrition Risk Screening and Related Factors Analysis of Non-hospitalized Cancer Survivors: A Nationwide Online Survey in China.

Authors:  Fang Wang; Qi Dong; Kang Yu; Rong-Rong Li; Ji Fu; Jia-Yu Guo; Chun-Wei Li
Journal:  Front Nutr       Date:  2022-06-21

4.  Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer.

Authors:  Zekai Shu; Baiqiang Dong; Lei Shi; Wei Shen; Qingqing Hang; Jin Wang; Yuanyuan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-24       Impact factor: 4.553

5.  Tri-country translation, cultural adaptation, and validity confirmation of the Scored Patient-Generated Subjective Global Assessment.

Authors:  Nicole Erickson; Lena J Storck; Alexandra Kolm; Kristina Norman; Theres Fey; Vanessa Schiffler; Faith D Ottery; Harriët Jager-Wittenaar
Journal:  Support Care Cancer       Date:  2019-01-25       Impact factor: 3.603

6.  Comparison of three common nutritional screening tools with the new European Society for Clinical Nutrition and Metabolism (ESPEN) criteria for malnutrition among patients with geriatric gastrointestinal cancer: a prospective study in China.

Authors:  Xiao-Jun Ye; Yan-Bin Ji; Bing-Wei Ma; Dong-Dong Huang; Wei-Zhe Chen; Zong-You Pan; Xian Shen; Cheng-Le Zhuang; Zhen Yu
Journal:  BMJ Open       Date:  2018-04-12       Impact factor: 2.692

7.  Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients.

Authors:  Anne Gingrich; Dorothee Volkert; Eva Kiesswetter; Marta Thomanek; Svenja Bach; Cornel C Sieber; Yurdagül Zopf
Journal:  BMC Geriatr       Date:  2019-04-27       Impact factor: 3.921

8.  Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).

Authors:  Johannes Laimer; Alexander Höller; Ute Pichler; Raphael Engel; Sabrina B Neururer; Alexander Egger; Andrea Griesmacher; Emanuel Bruckmoser
Journal:  Nutrients       Date:  2021-05-10       Impact factor: 5.717

9.  A low proportion of malnourished patients receive nutrition treatment - results from nutritionDay.

Authors:  C Henriksen; I M Gjelstad; H Nilssen; R Blomhoff
Journal:  Food Nutr Res       Date:  2017-10-25       Impact factor: 3.894

10.  Applications of the new ESPEN definition of malnutrition and SARC-F in Chinese nursing home residents.

Authors:  Ming Yang; Zhaojing Huang; Jing Chen; Jiaojiao Jiang; Yun Zuo; Qiukui Hao
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.